Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 28 December 2025
- Conf. stmt due
- 18 June 2027
- Last conf. stmt
- 4 June 2026
Immunodiagnostic Systems Holdings Limited
- Incorporated
- 4 June 2004 (22 years)
- Industry
- General medical practice activities (86210)
- Directors
- Dirk Beecker
- Owned by
- Accounts type
- Medium
- Region
- North East
- Address
- 10 Didcot WayBoldon Business ParkBoldon CollieryNE35 9PD
Charges
- Total
- 3
- Outstanding
- 0
- Part satisfied
- 0
- Satisfied
- 3
Officers 2 active
Officer details are public data from the Companies House register.
American
Born February 1960 (66)
Beecker, Dirk
Director · Appointed 3 January 2023
German
Born September 1965 (61)
Officer history (31 former)
13 October 2025
29 September 2025
12 January 2024
1 January 2024
31 December 2023
Resigned Stuut, Jaap as Director
3 January 2023
Appointed Beecker, Dirk as Director
31 December 2022
Resigned Schlumberger, Wolfgang, Dr as Director
18 January 2022
15 October 2021
Resigned Martin, Paul James as Director
15 October 2021
Resigned Martin, Paul James as Secretary
13 July 2021
Appointed Schlumberger, Wolfgang, Dr as Director
12 July 2021
12 July 2021
12 July 2021
Resigned Kaspar, Klaus Peter as Director
30 June 2018
Resigned Sackers, Roland as Director
30 June 2018
Resigned Campe, Till Bengt as Director
1 November 2017
Appointed Stuut, Jaap as Director
31 October 2017
Resigned Duval, Regis Jacques as Director
31 March 2017
Appointed Duval, Regis Jacques as Director
31 March 2017
Resigned Lacalle, Patricio as Director
15 March 2016
Appointed Martin, Paul James as Secretary
15 March 2016
Resigned Davison, Andrew John as Secretary
4 January 2016
Appointed Martin, Paul James as Director
1 November 2015
Appointed Kaspar, Klaus Peter as Director
4 August 2015
29 June 2015
15 June 2015
1 April 2015
Appointed Lacalle, Patricio as Director
4 January 2015
Resigned Dahlen, Patrik Olof, Dr as Director
25 November 2014
25 November 2014
Appointed Campe, Till Bengt as Director
25 November 2014
Resigned Martin, Anthony Francis, Dr as Director
6 March 2014
20 June 2013
Resigned Garrity, Martha Louise as Director
20 June 2013
Resigned Rousseau, Alain Michel as Director
4 March 2013
13 December 2012
Appointed Davison, Andrew John as Secretary
13 December 2012
Resigned Murray, Gerard Thomas as Secretary
30 November 2012
14 September 2012
22 June 2012
1 April 2012
Appointed Murray, Gerard Thomas as Secretary
1 April 2012
31 March 2012
31 March 2012
8 September 2011
8 September 2011
Appointed Martin, Anthony Francis, Dr as Director
1 September 2011
Resigned Wilks, Antony as Director
1 June 2011
Appointed Sackers, Roland as Director
11 December 2009
Appointed Dahlen, Patrik Olof, Dr as Director
20 October 2009
4 September 2009
1 November 2007
31 August 2007
Appointed Rousseau, Alain Michel as Director
1 February 2007
Appointed Garrity, Martha Louise as Director
26 January 2007
Appointed Wilks, Antony as Director
12 May 2006
Resigned Lee, Phillip Dukeal Kwaiy, Dr as Director
26 September 2005
Appointed Lee, Phillip Dukeal Kwaiy, Dr as Director
22 December 2004
22 December 2004
4 June 2004
4 June 2004
4 June 2004
4 June 2004
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Limited Company
Reg. no. 03758369
Former controllers (1)
12 July 2021
Group structure 9 companies
Ownership group derived from the Companies House PSC register
Horizon Discovery Group Limited Owns 75–100% of shares
Revvity Discovery Limited Owns 75–100% of shares
Horizon Discovery Biosciences Limited Owns 75–100% of shares
Immunodiagnostic Systems Holdings Limited This company Owns 75–100% of shares
Immunodiagnostic Systems Limited Owns 75–100% of shares
Oxford Immunotec Global Limited Owns 75–100% of shares
Revvity (UK) Limited Owns 75–100% of shares
Revvity Limited Owns 75–100% of shares
Financials
Figures from 2024 accounts. Newer accounts, made up to 28 December 2025, are filed but not read yet. See them on Companies House
- Net Assets
- £51,043,617
- Cash
- £3,510,420
- Profit Before Tax
- £1,011,641
- Debt Ratio
- 15%
- Current Ratio
- 2.8x
- Return on Equity
- 2%
Trend
Net Assets
Balance sheet detail
| 2024 | 2023 | |
|---|---|---|
| Fixed Assets | £35,292,066 | £35,320,602 |
| Current Assets | £24,747,990 | £34,256,989 |
| Debtors | £21,237,570 | £32,528,461 |
| Cash | £3,510,420 | £1,728,528 |
| Creditors (< 1 year) | £8,993,239 | £7,322,632 |
| Net Current Assets | £15,754,751 | £26,934,357 |
| Net Assets | £51,043,617 | £62,254,959 |
| Shareholder Funds | £51,043,617 | £62,254,959 |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 9 June 2026 | Confirmation statement with no updates | 4 June 2026 | ||
| 24 November 2025 | Full accounts | 29 December 2024 | ||
| 13 October 2025 | Termination of appointment of a director | |||
| 13 October 2025 | Appointment of a director | |||
| 10 June 2025 | Confirmation statement with no updates | 4 June 2025 |
Some other companies at this address
Other companies in this industry
Southampton
London
Ipswich
Brighton
Wincanton
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →